Indoor Harvest Corp (OTCQB: INQD) $25 million Sales Pipeline

Miami, FL -- June 15, 2016 -- InvestorsHub NewsWire -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Indoor Harvest Corp. (OTCQB: INQD).

Indoor Harvest Corp. (OTCQB: INQD) supplies aeroponic and hydroponic systems for organic produce production, systems for biomedical use, and systems for the cultivation and production of cannabis.

Indoor Harvest Corp. (OTCQB: INQD), which holds $25 million in its sales pipeline continues to see major growth in its industry and business over the long term.

Indoor Harvest Corp. (OTCQB: INQD)’s products are no joke. In fact, the company encourages full due diligence by prospective shareholders. The aeroponic farming company partnered with the Massachusetts Institute of Technology (MIT) in 2013, to supply the company’s patent-pending aeroponic technology to MIT’s Media Lab for their “Changing Places” project. The project allows MIT to use the aeroponic and vertical farming equipment for educational and study purposes.

Aside from their sales pipeline, with rumors of the DEA and federal government mulling cannabis rescheduling in the near future, Indoor Harvest Corp. (OTCQB: INQD) could be able to vastly expand its EPCM services for cannabis cultivation.

INQD also has an effective $2 million equity purchase agreement which will allow it to be able to maintain liquidity while finishing up projects and awaiting new projects to begin.

With over $25 million in Indoor Harvest Corp. (OTCQB: INQD)’s sales pipeline, the company could easily see its market cap expand into the double digit millions over the next year or two. The Company also recently announced international expansion plans which could considerably increase the Company's sales pipeline. In addition, with management seeing the potential for contracts worth over $10 million becoming available to the company by the end of 2016, the vertical farming company is prime to capitalize further from the coming vertical farming boom.

Please view the full report on EmergingGrowth.com for all editorial sources and hyperlinks.
http://emerginggrowth.com/indoor-harvest-corp-otcqb-inqd-25-million-sales-pipeline-10-million-contracts/

Other Companies In the Space or Recently Featured on EmergingGrowth.com:

GreenGo Technologies, Inc.
GreenGo Technologies, Inc. (OTC Pink: GRNH) is a manufacturer of vertical cultivation systems and designs to consumers and industrials farmers. The company entered the vertical cultivation business through its acquisition of Vertical Hydrogarden, Inc. As of June 2016, GreenGo Technologies, Inc. (OTC Pink: GRNH) has a market cap of nearly $13.8 million. As of December 2015, the vertical farming company had 500 million authorized shares and 267.5 million shares outstanding. Furthermore, GreenGo Technologies, Inc. (OTC Pink: GRNH) had a float of 160.4 million shares, as of June 2015. During full year 2015, the vertical cultivation company posted total revenues of $570,000, but a net income loss of $3.52 million.

Terra Tech Corp.
Terra Tech Corp. (OTCQX: TRTC) specializes in making technologies for controlling agricultural environment. Through its subsidiaries, the company is a producer of local hydroponic-grown produce that is sold through Shoprite, Food Emporium, and other supermarkets across six states. Terra Tech Corp. (OTCQX: TRTC) also engages in producing and cultivating marijuana for the medical cannabis industry. The hydroponic and medical marijuana company boasts a market cap of $136.6 million, through mid-June 2016. As of March 2016, the medical marijuana grower had over 463.04 million shares outstanding and a float of 216.44 million shares. During full year 2015, Terra Tech Corp. (OTCQX: TRTC) posted total revenue of $9.98 million, but a net income loss of $9.23 million.

Cantabio Pharmaceuticals Inc.
Neurodegenerative disease treatment company, Cantabio Pharmaceuticals Inc. (OTCQB: CTBO) has seen shares rise 6.40% in early morning trading on Tuesday, June 14, 2016. Over the past month, Cantabio Pharmaceuticals Inc. (OTCQB: CTBO) has seen average daily volume stand around 61,776 shares and the pharmaceutical company is on track to see share volume expand over its daily average, as nearly 40,000 shares or around $82,000 in dollar volume has already exchanged hands.

The Palo Alto, CA-based company has not seen any new updates hit the news waves, but Cantabio Pharmacetuicals Inc. (OTCQB: CTBO) was subject of a Seeking Alpha post that was published on June 13, 2016. In the article by Stone Fox Capital, the author acknowledges the risks and drawbacks to the company, but says “the small biotech has promising drug candidates in an area of extreme unmet needs and in need of workable solutions,” (Seeking Alpha). Alzheimer’s, dementia, and other neurodegenerative diseases continue to pose major health care issues, as limited treatment options are available.

About EmergingGrowth.com
EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

Disclaimer:
All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks. This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. Full details about which can be found in our full disclosure, which can be found here, http://www.emerginggrowth.com/disclosure-4673/. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.